Yarrow Bioscience Inc (YARW) Ownership

NASDAQ: YARWTop holders, insider trades and short interest.

YARW ownership summary

as of October 18, 2026
Institutions
38.2%
of shares outstanding
Insiders
2.02%
of shares outstanding
Shares outstanding
9.3M
Float
1.7M
shares available to trade
Short interest
—
190K shares short
Days to cover
1.15
short interest up 49.8% vs prior month
  • Institutions 38.22%
  • Insiders 2.02%
  • Other investors 59.76%

YARW top mutual fund and ETF holders

8 largest
Yarrow Bioscience Inc top fund holders
#Holder% of sharesSharesValueChangeReported
1Columbia Small Cap Growth Inst1.63%152K$2.8M+151,667 (0.0%)August 31, 2026
2Fidelity Extended Market Index0.03%2,821$51,653−15 (−0.5%)August 31, 2026
3Dimensional US Small Cap ETF0.01%816$14,941—September 30, 2026
4Fidelity Series Total Market Index0.01%694$12,707—August 31, 2026
5DFA US Social Core Equity 2 Portfolio0.01%547$10,016+547 (0.0%)August 31, 2026
6Fidelity Total Market Index<0.01%427$7,818—August 31, 2026
7DFA US Micro Cap I<0.01%17$311+17 (0.0%)August 31, 2026
8Fidelity Nasdaq Composite Index<0.01%7$128—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

YARW shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns YARW

Institutional investors own 38.2% of Yarrow Bioscience's shares and insiders 2.02%. The share count rose 108.9% since 2016.

Related: YARW analyst forecast, YARW key metrics. See the YARW stock overview for the latest quote and news.

YARW ownership FAQ

What percentage of Yarrow Bioscience is owned by institutions?

Institutions hold 38.2% of Yarrow Bioscience's shares outstanding; insiders hold 2.02%.

Which funds own Yarrow Bioscience?

The largest fund holders of Yarrow Bioscience are Columbia Small Cap Growth Inst (1.63%), Fidelity Extended Market Index (0.03%), Dimensional US Small Cap ETF (0.01%), Fidelity Series Total Market Index (0.01%), DFA US Social Core Equity 2 Portfolio (0.01%).

How many shares of Yarrow Bioscience are outstanding?

Yarrow Bioscience has 9.3M shares outstanding, of which 1.7M are in the public float.

Biotechnology: ownership